Skip to main content
SpringerLink
Log in
Book cover

Diagnosis and Management of Polycystic Ovary Syndrome pp 233–242Cite as

Therapy of Hirsutism

  • Chapter
  • First Online:

There has been a great deal of scientific research on the therapeutic aspects of PCOS/hirsutism/acne, which has intensified more recently. A PubMed search on “Treatment of polycystic ovary syndrome” returned 3580 items published in the 51 years comprised between 1957 and March 04, 2008; of these, 607 (17%) were in the 2 years, between Jan 01, 2006 and March 04, 2008. A PubMed search on “Treatment of hirsutism” returned 2211 items published in the 57 years comprised between 1951 and March 04, 2008; of these, 192 (9%) were in the 2 years between Jan 01, 2006 and March 04, 2008. At the recent 13th World Congress on Gynecological Endocrinology (Florence, February 28-March 02, 2008), 15 oral presentations and 3 posters focused on treatment of PCOS.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Kiddy DS, Hamilton-Fairley D, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36:105–11

    Article  CAS  Google Scholar 

  2. Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf). 2008 Feb 14 [Epub ahead of print]

    Google Scholar 

  3. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008; 23: 462–77

    Article  Google Scholar 

  4. Sonino N, Fava GA, Mani E et al. Quality of life of irsute women. Postgrad Med J 1993; 69:186–189

    Article  PubMed  CAS  Google Scholar 

  5. Shapiro J, Lui H. Vaniqa – eflornithine 13.9% cream. Skin Therapy Lett 2001; 6:1–3

    PubMed  CAS  Google Scholar 

  6. http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=14852 (accessed March 04, 2008)

  7. Califano L, Cannavò S, Siragusa M, et al. Experience in the therapy of acne with topical administration of spironolactone as an antiandrogen. Clin Ter 1990; 15;135:193–99

    Google Scholar 

  8. Berardesca E, Gabba P, Ucci G, et al. Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris. Int J Tissue React 1988; 10:115–19.

    PubMed  CAS  Google Scholar 

  9. Richards RN, Uy M, Meharg G. Temporary hair removal in patients with hirsutism: a clinical study. Cutis 1990; 45: 199–202.

    PubMed  CAS  Google Scholar 

  10. (http://www.fda.gov/cdrh/consumer/laserfacts.html updated February 28, 2008) (accessed, March 04, 2008)

    Google Scholar 

  11. Haedersdal M, Wulf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006; 20: 9–20

    Article  PubMed  CAS  Google Scholar 

  12. Sadighha A, Mohaghegh Zahed G. Meta-analysis of hair removal laser trials. Lasers Med Sci 2007 Nov 20 [Epub ahead of print]

    Google Scholar 

  13. Loo WJ, Lanigan SW. Laser treatment improves quality of life of hirsute females. Clin Exp Dermatol 2002; 27 :439–41

    Article  PubMed  CAS  Google Scholar 

  14. Clayton WJ, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005; 152: 986–92

    Article  PubMed  CAS  Google Scholar 

  15. Conroy FJ, Venus M, Monk B. A qualitative study to assess the effectiveness of laser epilation using a qualify-of-life scoring system. Clin Exp Dermatol 2006; 31:753–56

    Article  PubMed  CAS  Google Scholar 

  16. Hamzavi I, Tan E, Shapiro J, et al. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57:54–9.

    Article  PubMed  Google Scholar 

  17. Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007; 30: 471–78

    Article  PubMed  CAS  Google Scholar 

  18. http://www.notmypill.org/ (accessed March 04, 2008)

  19. Elter K, Imir G, Durmusoglu F. Clinical endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study. Human Reprod 2002; 17: 1729–37

    Article  CAS  Google Scholar 

  20. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, et al. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:2453–61

    Article  PubMed  Google Scholar 

  21. De Leo V, Fulghesu AM, La Marca A et al. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. Gynecol Endocrinol. 2000; 14:411–16

    Article  PubMed  Google Scholar 

  22. Carmina E, Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol (Oxf) 2002; 57:231–34.

    Article  CAS  Google Scholar 

  23. Swiglo BA, Cosma M, Flynn DN, et al. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008 Apr;93(4):1153–60. Epub 2008 Feb 5.

    Google Scholar 

  24. Ibáñez L, Jaramillo A, Ferrer A, et al. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005; 20:1833–36.

    Article  PubMed  Google Scholar 

  25. Ibáñez L, Ong K, Ferrer A, et al. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab 2003; 88:2600–06.

    Article  PubMed  Google Scholar 

  26. Ibáñez L, López-Bermejo A, del Rio L, et al. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 2007; 92:1710–14.

    Article  PubMed  Google Scholar 

  27. Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 1999; 84:1304–10

    CAS  Google Scholar 

  28. Moghetti P, Tosi F, Tosti A, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2000; 85:89–94

    Article  PubMed  CAS  Google Scholar 

  29. Müderris II, Bayram F, Güven M. prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 2000; 73:984–87

    Article  PubMed  Google Scholar 

  30. Farquhar C, Lee O Toomath R, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne Cochrane database Syst Rev 2003; 4:CD000194

    PubMed  Google Scholar 

  31. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane database Syst Rev 2003; 4:CD001125

    Google Scholar 

  32. Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study J Clin Endocrinol 2006; 91:3970–80

    Article  CAS  Google Scholar 

  33. Calaf J, Lopez E, Millet A, et al. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007; 92:3446–52

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Master on Childhood, Adolescent and Women’s Endocrine Health, University of Messina, Programma di Endocrinologia Molecolare Clinica, A.O.U. Policlinico G. Martino, Padiglione H, 4 piano, 98125, Messina, Italy

    Salvatore Benvenga

Authors
  1. Salvatore Benvenga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Benvenga .

Editor information

Editors and Affiliations

  1. The London Endocrine Clinic, 21 Wimpole Street, WIG 8GG, London, UK

    Nadir R. Farid

  2. University of Athens Medical School, Athens, Greece

    Evanthia Diamanti-Kandarakis

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Benvenga, S. (2009). Therapy of Hirsutism. In: Farid, N.R., Diamanti-Kandarakis, E. (eds) Diagnosis and Management of Polycystic Ovary Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09718-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-09718-3_19

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-09717-6

  • Online ISBN: 978-0-387-09718-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation